Shirley X. Chen, Ph.D., J.D. - Founder, CEO
Supported by an international team of biomedical researchers and business professionals in the US, Asia and Europe, Dr. Chen founded and leads WinVivo in its venture of developing innovative natural health and personal care products and services.
Dr. Chen brings in a unique combination of expertise and experience in the areas of natural product development and global market expansion, intellectual property (IP) protection and transactions, and brand management in the pharmaceutical, biotechnology and medical device industries. Complementary to her Silicon Valley business and legal expertise is her over 10 years of academic research in the US in the diverse areas of cancer biology, virology, immunology, molecular biology and biological chemistry.
Born in China to two botanist parents, Dr. Chen personally experiences and believes in the synergistic healing power of botanicals, and is committed to bringing the health benefits of natural products to many in need globally.
Prior to founding WinVivo, Dr. Chen served as president and CEO of MEBO International, Inc., a US subsidiary of MEBO International Group specialized in developing botanical products as regenerative medicine. Before joining MEBO, Dr. Chen was a senior IP counsel at Wilson Sonsini Goodrich & Rosati (WSGR), a premium international law firm acclaimed for bringing technology companies from early stages to public market success with clients such as Apple Computer, Google, and Genentech. At WSGR Dr. Chen provided strategic counseling to life sciences companies and investment firms in IP portfolio design and management, technology licensing, IP due diligence and risk assessment, which covered diverse areas of pharmaceuticals, biotechnology, medical devices, nutraceuticals and cosmeceuticals.
In her doctoral and postdoctoral research, Dr. Chen carried out interdisciplinary studies in interactions of small molecules with biomolecules in the development of innovative anti-cancer drugs and molecular diagnostics; and later as a principal investigator she led research in cancer biology and therapeutics development at SRI International (formerly Stanford Research Institute, Menlo Park, California).
Dr. Chen is a member of the State Bar of California, and registered to practice in front of the US Patent & Trademark Office. She received her J.D. from Santa Clara University School of Law; Ph.D. in Biological Chemistry from the State University of New York at Stony Brook. She was also a Damon Runyon Cancer Research Fund postdoctoral fellow investigating RNA virus (e.g., tumor virus, FIV, HIV) in the laboratories of Dr. Ignacio Tinoco (Member of the US National Academy of Sciences) at University of California, Berkeley and Dr. Harold E. Varmus (Nobel Laureate in Medicine/Physiology in 1989) at University of California, San Francisco.